How many insider declarations does HLB바이오스텝 have?

HLB바이오스텝 has filed 20 insider declarations with DART (FSS).

Who is the top reporting insider at HLB바이오스텝?

The top reporting insider at HLB바이오스텝 is HLB, based on the count of public filings.

What is the net insider buy vs sell volume on HLB바이오스텝?

Across the available history, declared buys total 1.3M€ and disposals 38.7M€.

InsiderTradesSIGMA

InsidersTradesSigma

HLB바이오스텝 (278650.KQ) — directors' dealings · Healthcare · insider

← Companies ★ Sign in to follow

HLB바이오스텝: directors' dealings · South Korea · DART (FSS)

DART:hlb-0f3bfaKR·DART (FSS)Mcap 80.8Bn€Healthcare

AMF ↗

Explore the full management transaction log of HLB바이오스텝, a listed issuer based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Healthcare sector, HLB바이오스텝 has logged 20 insider filings. Market capitalisation: €80.8bn. The latest transaction was disclosed on 11 May 2026 — Sale. Among the most active insiders: HLB. The full history is accessible without an account.

Insider Decl.

Thresholds

€1m

9 ops.

Buy Volume

€39m

10 ops.

Sell Volume

Financial data

FY ended December 2025 · cache

4785.00 €

Analyst consensus

Income statement

Revenue74.05 Bn€

Gross profit56.43 Bn€76% margin

Net income−18.96 Bn€-25.6% margin

Valuation

Beta-0.00

Balance sheet & cash

Market cap80.84 Bn€

Total debt30.76 Bn€

Free Cash Flow1.03 Bn€

Debt / Equity30%

Profitability & ownership

ROE-18.6%

ROA-3.3%

% insiders16.9%

% institutions0.5%

Last declaration on 11 May 2026

All Executives20 Thresholds Prospectus Other

Declarations20 total

Executives●Sale2DART

HLB

€39m14,087,156 shares

KRX

DART:20260511000277·11 May 2026